NCT06625970
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06625970
Title Study Evaluating the Efficacy and Safety of Darolutamide and Stereotactic Dose Escalated Radiotherapy in Patients With Localized Prostate Cancer and High-risk Features of Relapse (PEACE 7)
Acronym PEACE 7
Recruitment Recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors UNICANCER
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Clinique Pasteur Lanroze - Brest RECRUITING Brest France Details
Centre Georges Francois Leclerc RECRUITING Dijon France Details
Groupe Hospitalier Paris Saint-Joseph RECRUITING Paris France Details
CHU Saint-Etienne RECRUITING Saint-Etienne France Details
Gustave Roussy, Cancer Campus, Grand Paris RECRUITING Villejuif 94800 France Details
CHU Martinique RECRUITING Fort-de-France Martinique Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field